Literature DB >> 19465159

Insufficient evidence to conclude whether anti-tumor necrosis factor therapy increases the risk of lymphoma in Crohn's disease.

Laurent Peyrin-Biroulet, Jean-Frederic Colombel, William J Sandborn.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19465159     DOI： 10.1016/j.cgh.2009.05.012

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN： 1542-3565            Impact factor:   11.382


× No keyword cloud information.
  1 in total

1.  Declining use of combination infliximab and immunomodulator for inflammatory bowel disease in the community setting.

Authors:  Joshua C Berkowitz; Joanna Stein-Fishbein; Sundas Khan; Richard Furie; Keith S Sultan
Journal:  World J Gastrointest Pharmacol Ther       Date:  2018-02-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.